AUSTIN, Texas, July 1, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that the company has delivered the first of its new xMAP® INTELLIFLEX Systems to several of its Life ...

Luminex Corporation LMNX recently entered an agreement with EDP Biotech Corporation, wherein EDP will have the rights to develop, market and sell its blood-based colorectal cancer diagnostic assay, ...

Luminex Corporation LMNX recently delivered the first of its new xMAP INTELLIFLEX Systems to several of its Life Science Research Partners. This marks a significant milestone in the company’s strategy ...

HATFIELD, PA.--(BUSINESS WIRE)--Data-driven food allergy diagnostics company, AllerGenis, LLC today announced that it has entered into a non-exclusive agreement with Luminex Corporation (NASDAQ: LMNX) ...

Get to know Luminex’s xMAP® Technology all over again. For 27 years, xMAP Technology has become known as the worldwide leader in bead-based multiplexing. With the new xMAP INTELLIFLEX®, we have ...

AUSTIN, Texas, Feb. 16 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), a leading multiplex solutions developer, has announced speakers for its annual ...

The Tecan Group (SIX Swiss Exchange: TECN) and Luminex Corporation (Nasdaq: LMNX) have announced that they will collaborate on the development of a new automated newborn screening solution that will ...

Luminex Corporation has announced the agenda for its seventh annual Planet xMAP® USA multiplexing symposium. The event will be held May 12-14, 2010, at the Hilton Baltimore Hotel in Baltimore, ...

Luminex Corporation LMNX recently delivered the first of its new xMAP INTELLIFLEX Systems to several of its Life Science Research Partners. This marks a significant milestone in the company’s strategy ...

Luminex Corporation (NASDAQ:LMNX) recently entered an agreement with EDP Biotech Corporation, wherein EDP will have the rights to develop, market and sell its blood-based colorectal cancer diagnostic ...